ChromaDex to announce NR trial results this summer

OK sports fans, NR (a potential anti-aging vitamin B3 derivative) monopoly supplier ChromaDex has recently said that it will release the results of its 8 week 140 person trial of NR in groups of 35 at 100 mg, 300 mg, 1000 mg and a sugar cube with 0 mg of NR in June or July.

This may sway Elysium with its seven Nobel Prize laureates, who is being sued by Chromadex for withholding payment from last July*, to release the results of its own 8 week 120 person study (non-obese 60 to 80 year olds) taking NR at 250 mg, 500 mg and a sugar cube on its website from last summer faster than a science journal that will publish the results this year.

Website = fast; journal = slow.

I think it is possible that Elysium is withholding detailed results of changes in glucose levels, lipid levels, blood pressure, 6 minute walk test, etc. because they aren’t sure how to price NR with new information. That is, 500 mg a day, which is $1.80 for NR may prove much more effective than the current recommended 250 mg for $.90 a day. Just a hunch.

*Elysium knew the results of the first 4 weeks of its trial in late June, bought a lot more NR from wholesaler Chromadex, and insisted on lower price. ChromaDex balked at selling to Elysium at the much lower price and sued for payment that has been withhheld. At the same time, Elysium snared a pretty high level Chromadex employee to its company.

Advertisements
This entry was posted in Health Pills and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s